Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon(Centre National de la Recherche Scientifique), Ralf Jockers(Centre National de la Recherche Scientifique), Daniela Fernandois(Inserm), Corentin Bedart(Inserm), Nicolas Renault(Inserm), Sophie Le Poder(NeuroDiderot), Julie Dam(Centre National de la Recherche Scientifique), Charlotte Izabelle(Centre National de la Recherche Scientifique), Jan Wenzel(University of Lübeck), Caio Fernando Ferreira Coêlho(Inserm), Bernard Klonjkowski(École Nationale Vétérinaire d'Alfort), Sarah Gallet(Inserm), Vincent Prévot(Inserm), Markus Schwaninger(University of Lübeck)
Cited by 30
Related Papers
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
|Journal of Neuroscience|2008|410
The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
|Nature Neuroscience|2021|261
The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism
|Endocrine Reviews|2018|255